Clinical Trials Browser

Completed × Rectal Neoplasms × Dasatinib × Clear all

NCT04164069 2024-12-27

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00504153 2014-05-19

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Phase 2 Completed

19 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms